nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—ALB—Erlotinib—pancreatic cancer	0.0504	0.361	CbGbCtD
Acitretin—ALB—Irinotecan—pancreatic cancer	0.0455	0.326	CbGbCtD
Acitretin—ALB—Fluorouracil—pancreatic cancer	0.0436	0.313	CbGbCtD
Acitretin—Somnolence—Fluorouracil—pancreatic cancer	0.00029	0.0005	CcSEcCtD
Acitretin—Erythema—Docetaxel—pancreatic cancer	0.000289	0.000497	CcSEcCtD
Acitretin—Decreased appetite—Gemcitabine—pancreatic cancer	0.000289	0.000497	CcSEcCtD
Acitretin—Dyspepsia—Fluorouracil—pancreatic cancer	0.000288	0.000495	CcSEcCtD
Acitretin—Nausea—Tamoxifen—pancreatic cancer	0.000287	0.000494	CcSEcCtD
Acitretin—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000287	0.000493	CcSEcCtD
Acitretin—Fatigue—Gemcitabine—pancreatic cancer	0.000286	0.000493	CcSEcCtD
Acitretin—Gastritis—Epirubicin—pancreatic cancer	0.000286	0.000493	CcSEcCtD
Acitretin—Muscular weakness—Epirubicin—pancreatic cancer	0.000285	0.000491	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000285	0.000491	CcSEcCtD
Acitretin—Pain—Gemcitabine—pancreatic cancer	0.000284	0.000489	CcSEcCtD
Acitretin—Constipation—Gemcitabine—pancreatic cancer	0.000284	0.000489	CcSEcCtD
Acitretin—Nausea—Erlotinib—pancreatic cancer	0.000284	0.000489	CcSEcCtD
Acitretin—Decreased appetite—Fluorouracil—pancreatic cancer	0.000284	0.000488	CcSEcCtD
Acitretin—Diarrhoea—Sunitinib—pancreatic cancer	0.000283	0.000487	CcSEcCtD
Acitretin—Dysgeusia—Docetaxel—pancreatic cancer	0.000283	0.000487	CcSEcCtD
Acitretin—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000282	0.000485	CcSEcCtD
Acitretin—Feeling abnormal—Irinotecan—pancreatic cancer	0.000281	0.000483	CcSEcCtD
Acitretin—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.00028	0.000482	CcSEcCtD
Acitretin—Back pain—Docetaxel—pancreatic cancer	0.000279	0.000481	CcSEcCtD
Acitretin—Pain—Fluorouracil—pancreatic cancer	0.000279	0.00048	CcSEcCtD
Acitretin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000279	0.00048	CcSEcCtD
Acitretin—Muscle spasms—Docetaxel—pancreatic cancer	0.000278	0.000478	CcSEcCtD
Acitretin—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000276	0.000475	CcSEcCtD
Acitretin—Dry skin—Doxorubicin—pancreatic cancer	0.000274	0.000472	CcSEcCtD
Acitretin—Pancreatitis—Epirubicin—pancreatic cancer	0.000274	0.000472	CcSEcCtD
Acitretin—Dizziness—Sunitinib—pancreatic cancer	0.000274	0.000471	CcSEcCtD
Acitretin—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000274	0.000471	CcSEcCtD
Acitretin—Abdominal pain—Irinotecan—pancreatic cancer	0.00027	0.000464	CcSEcCtD
Acitretin—Body temperature increased—Irinotecan—pancreatic cancer	0.00027	0.000464	CcSEcCtD
Acitretin—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000269	0.000463	CcSEcCtD
Acitretin—Pancytopenia—Epirubicin—pancreatic cancer	0.000266	0.000457	CcSEcCtD
Acitretin—Gastritis—Doxorubicin—pancreatic cancer	0.000265	0.000456	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000264	0.000454	CcSEcCtD
Acitretin—Muscular weakness—Doxorubicin—pancreatic cancer	0.000264	0.000454	CcSEcCtD
Acitretin—Vomiting—Sunitinib—pancreatic cancer	0.000263	0.000453	CcSEcCtD
Acitretin—Body temperature increased—Gemcitabine—pancreatic cancer	0.000263	0.000452	CcSEcCtD
Acitretin—Dysuria—Epirubicin—pancreatic cancer	0.000261	0.00045	CcSEcCtD
Acitretin—Rash—Sunitinib—pancreatic cancer	0.000261	0.000449	CcSEcCtD
Acitretin—Dermatitis—Sunitinib—pancreatic cancer	0.000261	0.000449	CcSEcCtD
Acitretin—Urticaria—Fluorouracil—pancreatic cancer	0.000259	0.000446	CcSEcCtD
Acitretin—Headache—Sunitinib—pancreatic cancer	0.000259	0.000446	CcSEcCtD
Acitretin—Body temperature increased—Fluorouracil—pancreatic cancer	0.000258	0.000444	CcSEcCtD
Acitretin—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000255	0.000439	CcSEcCtD
Acitretin—Weight increased—Epirubicin—pancreatic cancer	0.000254	0.000438	CcSEcCtD
Acitretin—Pancreatitis—Doxorubicin—pancreatic cancer	0.000254	0.000436	CcSEcCtD
Acitretin—Weight decreased—Epirubicin—pancreatic cancer	0.000253	0.000435	CcSEcCtD
Acitretin—Cough—Docetaxel—pancreatic cancer	0.000252	0.000434	CcSEcCtD
Acitretin—Hypersensitivity—Irinotecan—pancreatic cancer	0.000251	0.000432	CcSEcCtD
Acitretin—Myalgia—Docetaxel—pancreatic cancer	0.000246	0.000423	CcSEcCtD
Acitretin—Chest pain—Docetaxel—pancreatic cancer	0.000246	0.000423	CcSEcCtD
Acitretin—Arthralgia—Docetaxel—pancreatic cancer	0.000246	0.000423	CcSEcCtD
Acitretin—Nausea—Sunitinib—pancreatic cancer	0.000246	0.000423	CcSEcCtD
Acitretin—Pancytopenia—Doxorubicin—pancreatic cancer	0.000246	0.000423	CcSEcCtD
Acitretin—Asthenia—Irinotecan—pancreatic cancer	0.000245	0.000421	CcSEcCtD
Acitretin—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000244	0.00042	CcSEcCtD
Acitretin—Stomatitis—Epirubicin—pancreatic cancer	0.000243	0.000418	CcSEcCtD
Acitretin—Jaundice—Epirubicin—pancreatic cancer	0.000243	0.000418	CcSEcCtD
Acitretin—Conjunctivitis—Epirubicin—pancreatic cancer	0.000242	0.000417	CcSEcCtD
Acitretin—Urinary tract infection—Epirubicin—pancreatic cancer	0.000242	0.000417	CcSEcCtD
Acitretin—Dysuria—Doxorubicin—pancreatic cancer	0.000242	0.000416	CcSEcCtD
Acitretin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000241	0.000414	CcSEcCtD
Acitretin—Dry mouth—Docetaxel—pancreatic cancer	0.000241	0.000414	CcSEcCtD
Acitretin—Asthenia—Gemcitabine—pancreatic cancer	0.000238	0.00041	CcSEcCtD
Acitretin—Haematuria—Epirubicin—pancreatic cancer	0.000238	0.000409	CcSEcCtD
Acitretin—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000236	0.000406	CcSEcCtD
Acitretin—Oedema—Docetaxel—pancreatic cancer	0.000236	0.000406	CcSEcCtD
Acitretin—Weight increased—Doxorubicin—pancreatic cancer	0.000235	0.000405	CcSEcCtD
Acitretin—Epistaxis—Epirubicin—pancreatic cancer	0.000235	0.000405	CcSEcCtD
Acitretin—Pruritus—Gemcitabine—pancreatic cancer	0.000235	0.000404	CcSEcCtD
Acitretin—Infection—Docetaxel—pancreatic cancer	0.000234	0.000403	CcSEcCtD
Acitretin—Weight decreased—Doxorubicin—pancreatic cancer	0.000234	0.000403	CcSEcCtD
Acitretin—Sinusitis—Epirubicin—pancreatic cancer	0.000234	0.000402	CcSEcCtD
Acitretin—Diarrhoea—Irinotecan—pancreatic cancer	0.000233	0.000401	CcSEcCtD
Acitretin—Pruritus—Fluorouracil—pancreatic cancer	0.000231	0.000398	CcSEcCtD
Acitretin—Skin disorder—Docetaxel—pancreatic cancer	0.000229	0.000394	CcSEcCtD
Acitretin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000227	0.000391	CcSEcCtD
Acitretin—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000226	0.000389	CcSEcCtD
Acitretin—Dizziness—Irinotecan—pancreatic cancer	0.000226	0.000388	CcSEcCtD
Acitretin—Haemoglobin—Epirubicin—pancreatic cancer	0.000225	0.000387	CcSEcCtD
Acitretin—Stomatitis—Doxorubicin—pancreatic cancer	0.000225	0.000387	CcSEcCtD
Acitretin—Jaundice—Doxorubicin—pancreatic cancer	0.000225	0.000387	CcSEcCtD
Acitretin—Anorexia—Docetaxel—pancreatic cancer	0.000225	0.000387	CcSEcCtD
Acitretin—Rhinitis—Epirubicin—pancreatic cancer	0.000224	0.000386	CcSEcCtD
Acitretin—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000224	0.000386	CcSEcCtD
Acitretin—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000224	0.000386	CcSEcCtD
Acitretin—Hepatitis—Epirubicin—pancreatic cancer	0.000224	0.000385	CcSEcCtD
Acitretin—Haemorrhage—Epirubicin—pancreatic cancer	0.000224	0.000385	CcSEcCtD
Acitretin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000223	0.000384	CcSEcCtD
Acitretin—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000223	0.000383	CcSEcCtD
Acitretin—Pharyngitis—Epirubicin—pancreatic cancer	0.000222	0.000382	CcSEcCtD
Acitretin—Oedema peripheral—Epirubicin—pancreatic cancer	0.00022	0.000379	CcSEcCtD
Acitretin—Haematuria—Doxorubicin—pancreatic cancer	0.00022	0.000378	CcSEcCtD
Acitretin—Epistaxis—Doxorubicin—pancreatic cancer	0.000218	0.000374	CcSEcCtD
Acitretin—Vomiting—Irinotecan—pancreatic cancer	0.000217	0.000373	CcSEcCtD
Acitretin—Sinusitis—Doxorubicin—pancreatic cancer	0.000216	0.000372	CcSEcCtD
Acitretin—Dizziness—Fluorouracil—pancreatic cancer	0.000216	0.000372	CcSEcCtD
Acitretin—Visual impairment—Epirubicin—pancreatic cancer	0.000216	0.000371	CcSEcCtD
Acitretin—Rash—Irinotecan—pancreatic cancer	0.000215	0.00037	CcSEcCtD
Acitretin—Dermatitis—Irinotecan—pancreatic cancer	0.000215	0.00037	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000215	0.000369	CcSEcCtD
Acitretin—Headache—Irinotecan—pancreatic cancer	0.000214	0.000368	CcSEcCtD
Acitretin—Insomnia—Docetaxel—pancreatic cancer	0.000213	0.000367	CcSEcCtD
Acitretin—Paraesthesia—Docetaxel—pancreatic cancer	0.000212	0.000364	CcSEcCtD
Acitretin—Vomiting—Gemcitabine—pancreatic cancer	0.000211	0.000363	CcSEcCtD
Acitretin—Somnolence—Docetaxel—pancreatic cancer	0.00021	0.000361	CcSEcCtD
Acitretin—Rash—Gemcitabine—pancreatic cancer	0.000209	0.00036	CcSEcCtD
Acitretin—Dermatitis—Gemcitabine—pancreatic cancer	0.000209	0.00036	CcSEcCtD
Acitretin—Eye disorder—Epirubicin—pancreatic cancer	0.000209	0.00036	CcSEcCtD
Acitretin—Tinnitus—Epirubicin—pancreatic cancer	0.000209	0.000359	CcSEcCtD
Acitretin—Haemoglobin—Doxorubicin—pancreatic cancer	0.000208	0.000358	CcSEcCtD
Acitretin—Headache—Gemcitabine—pancreatic cancer	0.000208	0.000358	CcSEcCtD
Acitretin—Flushing—Epirubicin—pancreatic cancer	0.000208	0.000357	CcSEcCtD
Acitretin—Vomiting—Fluorouracil—pancreatic cancer	0.000208	0.000357	CcSEcCtD
Acitretin—Rhinitis—Doxorubicin—pancreatic cancer	0.000208	0.000357	CcSEcCtD
Acitretin—Dyspepsia—Docetaxel—pancreatic cancer	0.000208	0.000357	CcSEcCtD
Acitretin—Haemorrhage—Doxorubicin—pancreatic cancer	0.000207	0.000356	CcSEcCtD
Acitretin—Hepatitis—Doxorubicin—pancreatic cancer	0.000207	0.000356	CcSEcCtD
Acitretin—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000206	0.000354	CcSEcCtD
Acitretin—Rash—Fluorouracil—pancreatic cancer	0.000206	0.000354	CcSEcCtD
Acitretin—Dermatitis—Fluorouracil—pancreatic cancer	0.000206	0.000354	CcSEcCtD
Acitretin—Pharyngitis—Doxorubicin—pancreatic cancer	0.000206	0.000354	CcSEcCtD
Acitretin—Decreased appetite—Docetaxel—pancreatic cancer	0.000205	0.000353	CcSEcCtD
Acitretin—Headache—Fluorouracil—pancreatic cancer	0.000205	0.000352	CcSEcCtD
Acitretin—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000204	0.000351	CcSEcCtD
Acitretin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000204	0.00035	CcSEcCtD
Acitretin—Fatigue—Docetaxel—pancreatic cancer	0.000203	0.00035	CcSEcCtD
Acitretin—Angiopathy—Epirubicin—pancreatic cancer	0.000203	0.000349	CcSEcCtD
Acitretin—Nausea—Irinotecan—pancreatic cancer	0.000203	0.000348	CcSEcCtD
Acitretin—Immune system disorder—Epirubicin—pancreatic cancer	0.000202	0.000348	CcSEcCtD
Acitretin—Constipation—Docetaxel—pancreatic cancer	0.000202	0.000347	CcSEcCtD
Acitretin—Pain—Docetaxel—pancreatic cancer	0.000202	0.000347	CcSEcCtD
Acitretin—Chills—Epirubicin—pancreatic cancer	0.000201	0.000345	CcSEcCtD
Acitretin—Visual impairment—Doxorubicin—pancreatic cancer	0.0002	0.000343	CcSEcCtD
Acitretin—Alopecia—Epirubicin—pancreatic cancer	0.000198	0.00034	CcSEcCtD
Acitretin—Nausea—Gemcitabine—pancreatic cancer	0.000197	0.000339	CcSEcCtD
Acitretin—Erythema—Epirubicin—pancreatic cancer	0.000195	0.000335	CcSEcCtD
Acitretin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000194	0.000334	CcSEcCtD
Acitretin—Nausea—Fluorouracil—pancreatic cancer	0.000194	0.000334	CcSEcCtD
Acitretin—Eye disorder—Doxorubicin—pancreatic cancer	0.000194	0.000333	CcSEcCtD
Acitretin—Tinnitus—Doxorubicin—pancreatic cancer	0.000193	0.000332	CcSEcCtD
Acitretin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000193	0.000332	CcSEcCtD
Acitretin—Flushing—Doxorubicin—pancreatic cancer	0.000192	0.000331	CcSEcCtD
Acitretin—Tension—Epirubicin—pancreatic cancer	0.000191	0.000329	CcSEcCtD
Acitretin—Dysgeusia—Epirubicin—pancreatic cancer	0.000191	0.000328	CcSEcCtD
Acitretin—Nervousness—Epirubicin—pancreatic cancer	0.000189	0.000326	CcSEcCtD
Acitretin—Back pain—Epirubicin—pancreatic cancer	0.000188	0.000324	CcSEcCtD
Acitretin—Angiopathy—Doxorubicin—pancreatic cancer	0.000188	0.000323	CcSEcCtD
Acitretin—Muscle spasms—Epirubicin—pancreatic cancer	0.000187	0.000322	CcSEcCtD
Acitretin—Immune system disorder—Doxorubicin—pancreatic cancer	0.000187	0.000322	CcSEcCtD
Acitretin—Abdominal pain—Docetaxel—pancreatic cancer	0.000186	0.000321	CcSEcCtD
Acitretin—Body temperature increased—Docetaxel—pancreatic cancer	0.000186	0.000321	CcSEcCtD
Acitretin—Chills—Doxorubicin—pancreatic cancer	0.000186	0.00032	CcSEcCtD
Acitretin—Vision blurred—Epirubicin—pancreatic cancer	0.000184	0.000316	CcSEcCtD
Acitretin—Alopecia—Doxorubicin—pancreatic cancer	0.000183	0.000315	CcSEcCtD
Acitretin—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000181	0.000311	CcSEcCtD
Acitretin—Erythema—Doxorubicin—pancreatic cancer	0.00018	0.00031	CcSEcCtD
Acitretin—RXRG—Gene Expression—HSPA1A—pancreatic cancer	0.000178	0.000638	CbGpPWpGaD
Acitretin—Tension—Doxorubicin—pancreatic cancer	0.000177	0.000304	CcSEcCtD
Acitretin—RARA—Gene Expression—NOTCH3—pancreatic cancer	0.000177	0.000633	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—NOTCH3—pancreatic cancer	0.000177	0.000633	CbGpPWpGaD
Acitretin—Dysgeusia—Doxorubicin—pancreatic cancer	0.000177	0.000304	CcSEcCtD
Acitretin—CYP26A1—Metabolism—GCG—pancreatic cancer	0.000176	0.000632	CbGpPWpGaD
Acitretin—Malaise—Epirubicin—pancreatic cancer	0.000176	0.000302	CcSEcCtD
Acitretin—Nervousness—Doxorubicin—pancreatic cancer	0.000175	0.000301	CcSEcCtD
Acitretin—RARB—Gene Expression—HSPA1A—pancreatic cancer	0.000175	0.000625	CbGpPWpGaD
Acitretin—Back pain—Doxorubicin—pancreatic cancer	0.000174	0.0003	CcSEcCtD
Acitretin—RBP1—Disease—HIF1A—pancreatic cancer	0.000174	0.000624	CbGpPWpGaD
Acitretin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000174	0.000299	CcSEcCtD
Acitretin—RBP1—Disease—TSC2—pancreatic cancer	0.000174	0.000622	CbGpPWpGaD
Acitretin—Muscle spasms—Doxorubicin—pancreatic cancer	0.000173	0.000298	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—AGTR1—pancreatic cancer	0.000173	0.000618	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—STK11—pancreatic cancer	0.00017	0.000609	CbGpPWpGaD
Acitretin—Cough—Epirubicin—pancreatic cancer	0.00017	0.000292	CcSEcCtD
Acitretin—RBP1—Disease—APOE—pancreatic cancer	0.00017	0.000609	CbGpPWpGaD
Acitretin—Vision blurred—Doxorubicin—pancreatic cancer	0.00017	0.000292	CcSEcCtD
Acitretin—Asthenia—Docetaxel—pancreatic cancer	0.000169	0.000291	CcSEcCtD
Acitretin—ALB—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000169	0.000606	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—STAT3—pancreatic cancer	0.000168	0.000603	CbGpPWpGaD
Acitretin—RARA—Gene Expression—HSPA1A—pancreatic cancer	0.000167	0.0006	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—HSPA1A—pancreatic cancer	0.000167	0.0006	CbGpPWpGaD
Acitretin—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000167	0.000288	CcSEcCtD
Acitretin—Pruritus—Docetaxel—pancreatic cancer	0.000167	0.000287	CcSEcCtD
Acitretin—Chest pain—Epirubicin—pancreatic cancer	0.000166	0.000285	CcSEcCtD
Acitretin—Arthralgia—Epirubicin—pancreatic cancer	0.000166	0.000285	CcSEcCtD
Acitretin—Myalgia—Epirubicin—pancreatic cancer	0.000166	0.000285	CcSEcCtD
Acitretin—CYP26A1—Metabolism—STK11—pancreatic cancer	0.000166	0.000594	CbGpPWpGaD
Acitretin—Anxiety—Epirubicin—pancreatic cancer	0.000165	0.000284	CcSEcCtD
Acitretin—Discomfort—Epirubicin—pancreatic cancer	0.000164	0.000282	CcSEcCtD
Acitretin—Malaise—Doxorubicin—pancreatic cancer	0.000163	0.00028	CcSEcCtD
Acitretin—Dry mouth—Epirubicin—pancreatic cancer	0.000162	0.000279	CcSEcCtD
Acitretin—Diarrhoea—Docetaxel—pancreatic cancer	0.000161	0.000277	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	0.00016	0.000572	CbGpPWpGaD
Acitretin—Oedema—Epirubicin—pancreatic cancer	0.000159	0.000274	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.000159	0.000569	CbGpPWpGaD
Acitretin—Infection—Epirubicin—pancreatic cancer	0.000158	0.000272	CcSEcCtD
Acitretin—Cough—Doxorubicin—pancreatic cancer	0.000157	0.000271	CcSEcCtD
Acitretin—RBP1—Disease—NOTCH1—pancreatic cancer	0.000157	0.000562	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—TGFB1—pancreatic cancer	0.000156	0.000559	CbGpPWpGaD
Acitretin—Dizziness—Docetaxel—pancreatic cancer	0.000156	0.000268	CcSEcCtD
Acitretin—RARG—Gene Expression—SMAD4—pancreatic cancer	0.000155	0.000554	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PRSS1—pancreatic cancer	0.000155	0.000554	CbGpPWpGaD
Acitretin—Skin disorder—Epirubicin—pancreatic cancer	0.000154	0.000266	CcSEcCtD
Acitretin—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000154	0.000264	CcSEcCtD
Acitretin—Myalgia—Doxorubicin—pancreatic cancer	0.000153	0.000264	CcSEcCtD
Acitretin—Chest pain—Doxorubicin—pancreatic cancer	0.000153	0.000264	CcSEcCtD
Acitretin—Arthralgia—Doxorubicin—pancreatic cancer	0.000153	0.000264	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	0.000153	0.000548	CbGpPWpGaD
Acitretin—Anxiety—Doxorubicin—pancreatic cancer	0.000153	0.000263	CcSEcCtD
Acitretin—Discomfort—Doxorubicin—pancreatic cancer	0.000152	0.000261	CcSEcCtD
Acitretin—RBP1—Disease—EGF—pancreatic cancer	0.000152	0.000543	CbGpPWpGaD
Acitretin—Anorexia—Epirubicin—pancreatic cancer	0.000152	0.000261	CcSEcCtD
Acitretin—Dry mouth—Doxorubicin—pancreatic cancer	0.00015	0.000258	CcSEcCtD
Acitretin—Vomiting—Docetaxel—pancreatic cancer	0.00015	0.000258	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—SMAD4—pancreatic cancer	0.000149	0.000534	CbGpPWpGaD
Acitretin—Rash—Docetaxel—pancreatic cancer	0.000149	0.000256	CcSEcCtD
Acitretin—Dermatitis—Docetaxel—pancreatic cancer	0.000149	0.000255	CcSEcCtD
Acitretin—Headache—Docetaxel—pancreatic cancer	0.000148	0.000254	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.000147	0.000528	CbGpPWpGaD
Acitretin—Oedema—Doxorubicin—pancreatic cancer	0.000147	0.000253	CcSEcCtD
Acitretin—Infection—Doxorubicin—pancreatic cancer	0.000146	0.000251	CcSEcCtD
Acitretin—RXRA—Adipogenesis—TNF—pancreatic cancer	0.000146	0.000522	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—HES1—pancreatic cancer	0.000145	0.000521	CbGpPWpGaD
Acitretin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000145	0.000249	CcSEcCtD
Acitretin—RXRA—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000144	0.000516	CbGpPWpGaD
Acitretin—Insomnia—Epirubicin—pancreatic cancer	0.000144	0.000247	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.000143	0.000514	CbGpPWpGaD
Acitretin—Skin disorder—Doxorubicin—pancreatic cancer	0.000143	0.000246	CcSEcCtD
Acitretin—Paraesthesia—Epirubicin—pancreatic cancer	0.000143	0.000246	CcSEcCtD
Acitretin—CYP26A1—Metabolism—TYMS—pancreatic cancer	0.000143	0.000511	CbGpPWpGaD
Acitretin—RXRA—NRF2 pathway—TGFB1—pancreatic cancer	0.000142	0.00051	CbGpPWpGaD
Acitretin—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000142	0.000245	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.000142	0.000509	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—SMAD4—pancreatic cancer	0.000142	0.000507	CbGpPWpGaD
Acitretin—Somnolence—Epirubicin—pancreatic cancer	0.000141	0.000243	CcSEcCtD
Acitretin—ALB—Vitamin B12 Metabolism—TNF—pancreatic cancer	0.000141	0.000504	CbGpPWpGaD
Acitretin—Anorexia—Doxorubicin—pancreatic cancer	0.00014	0.000241	CcSEcCtD
Acitretin—Nausea—Docetaxel—pancreatic cancer	0.00014	0.000241	CcSEcCtD
Acitretin—Dyspepsia—Epirubicin—pancreatic cancer	0.00014	0.000241	CcSEcCtD
Acitretin—RARB—Gene Expression—SMAD4—pancreatic cancer	0.000139	0.000497	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.000138	0.000496	CbGpPWpGaD
Acitretin—Decreased appetite—Epirubicin—pancreatic cancer	0.000138	0.000238	CcSEcCtD
Acitretin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000137	0.000236	CcSEcCtD
Acitretin—Fatigue—Epirubicin—pancreatic cancer	0.000137	0.000236	CcSEcCtD
Acitretin—Constipation—Epirubicin—pancreatic cancer	0.000136	0.000234	CcSEcCtD
Acitretin—Pain—Epirubicin—pancreatic cancer	0.000136	0.000234	CcSEcCtD
Acitretin—ALB—Hemostasis—IFNA5—pancreatic cancer	0.000136	0.000487	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—SMAD4—pancreatic cancer	0.000136	0.000486	CbGpPWpGaD
Acitretin—RBP1—Disease—PIK3CD—pancreatic cancer	0.000135	0.000483	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—PTGS2—pancreatic cancer	0.000135	0.000482	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ARG2—pancreatic cancer	0.000134	0.00048	CbGpPWpGaD
Acitretin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000134	0.000231	CcSEcCtD
Acitretin—RARA—Gene Expression—SMAD4—pancreatic cancer	0.000133	0.000477	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—SMAD4—pancreatic cancer	0.000133	0.000477	CbGpPWpGaD
Acitretin—Insomnia—Doxorubicin—pancreatic cancer	0.000133	0.000229	CcSEcCtD
Acitretin—RXRA—Developmental Biology—HES1—pancreatic cancer	0.000132	0.000474	CbGpPWpGaD
Acitretin—Paraesthesia—Doxorubicin—pancreatic cancer	0.000132	0.000227	CcSEcCtD
Acitretin—Feeling abnormal—Epirubicin—pancreatic cancer	0.000131	0.000225	CcSEcCtD
Acitretin—Somnolence—Doxorubicin—pancreatic cancer	0.000131	0.000225	CcSEcCtD
Acitretin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00013	0.000224	CcSEcCtD
Acitretin—Dyspepsia—Doxorubicin—pancreatic cancer	0.00013	0.000223	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	0.000128	0.00046	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PPP2R5B—pancreatic cancer	0.000128	0.00046	CbGpPWpGaD
Acitretin—Decreased appetite—Doxorubicin—pancreatic cancer	0.000128	0.00022	CcSEcCtD
Acitretin—RARG—Generic Transcription Pathway—MYC—pancreatic cancer	0.000128	0.000457	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TERT—pancreatic cancer	0.000127	0.000457	CbGpPWpGaD
Acitretin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000127	0.000219	CcSEcCtD
Acitretin—Fatigue—Doxorubicin—pancreatic cancer	0.000127	0.000218	CcSEcCtD
Acitretin—Urticaria—Epirubicin—pancreatic cancer	0.000126	0.000217	CcSEcCtD
Acitretin—Pain—Doxorubicin—pancreatic cancer	0.000126	0.000216	CcSEcCtD
Acitretin—Constipation—Doxorubicin—pancreatic cancer	0.000126	0.000216	CcSEcCtD
Acitretin—Body temperature increased—Epirubicin—pancreatic cancer	0.000126	0.000216	CcSEcCtD
Acitretin—Abdominal pain—Epirubicin—pancreatic cancer	0.000126	0.000216	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	0.000125	0.000448	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—HIF1A—pancreatic cancer	0.000122	0.000437	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TSC2—pancreatic cancer	0.000122	0.000436	CbGpPWpGaD
Acitretin—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000121	0.000209	CcSEcCtD
Acitretin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00012	0.000207	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—APOE—pancreatic cancer	0.000119	0.000426	CbGpPWpGaD
Acitretin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	0.000118	0.000422	CbGpPWpGaD
Acitretin—RBP1—Disease—PIK3CB—pancreatic cancer	0.000118	0.000421	CbGpPWpGaD
Acitretin—RXRA—Metabolism—TYMP—pancreatic cancer	0.000117	0.00042	CbGpPWpGaD
Acitretin—Hypersensitivity—Epirubicin—pancreatic cancer	0.000117	0.000202	CcSEcCtD
Acitretin—Urticaria—Doxorubicin—pancreatic cancer	0.000117	0.000201	CcSEcCtD
Acitretin—RXRG—Generic Transcription Pathway—MYC—pancreatic cancer	0.000117	0.000418	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KDR—pancreatic cancer	0.000117	0.000418	CbGpPWpGaD
Acitretin—RBP1—Disease—PTGS2—pancreatic cancer	0.000116	0.000417	CbGpPWpGaD
Acitretin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000116	0.0002	CcSEcCtD
Acitretin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000116	0.0002	CcSEcCtD
Acitretin—CYP26A1—Metabolism—APOE—pancreatic cancer	0.000116	0.000416	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	0.000115	0.000412	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	0.000115	0.000411	CbGpPWpGaD
Acitretin—ALB—Platelet degranulation—VEGFA—pancreatic cancer	0.000114	0.00041	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—MYC—pancreatic cancer	0.000114	0.00041	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TNF—pancreatic cancer	0.000114	0.00041	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MEN1—pancreatic cancer	0.000114	0.000409	CbGpPWpGaD
Acitretin—RARG—Gene Expression—NOTCH1—pancreatic cancer	0.000114	0.000409	CbGpPWpGaD
Acitretin—Asthenia—Epirubicin—pancreatic cancer	0.000114	0.000196	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	0.000113	0.000403	CbGpPWpGaD
Acitretin—Pruritus—Epirubicin—pancreatic cancer	0.000113	0.000194	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—NFKBIA—pancreatic cancer	0.000111	0.000397	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NOTCH1—pancreatic cancer	0.00011	0.000393	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—MYC—pancreatic cancer	0.00011	0.000393	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—MYC—pancreatic cancer	0.00011	0.000393	CbGpPWpGaD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—pancreatic cancer	0.000109	0.00039	CbGpPWpGaD
Acitretin—Diarrhoea—Epirubicin—pancreatic cancer	0.000109	0.000187	CcSEcCtD
Acitretin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000108	0.000186	CcSEcCtD
Acitretin—RXRA—Gene Expression—NOTCH4—pancreatic cancer	0.000108	0.000388	CbGpPWpGaD
Acitretin—RARG—Gene Expression—PPARG—pancreatic cancer	0.000108	0.000386	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CG—pancreatic cancer	0.000107	0.000385	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	0.000107	0.000384	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	0.000106	0.000381	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000106	0.00038	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—EGF—pancreatic cancer	0.000106	0.00038	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—KDR—pancreatic cancer	0.000106	0.00038	CbGpPWpGaD
Acitretin—Asthenia—Doxorubicin—pancreatic cancer	0.000106	0.000182	CcSEcCtD
Acitretin—Dizziness—Epirubicin—pancreatic cancer	0.000105	0.000181	CcSEcCtD
Acitretin—ALB—Platelet degranulation—TGFB1—pancreatic cancer	0.000105	0.000376	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CG—pancreatic cancer	0.000105	0.000375	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—NOTCH1—pancreatic cancer	0.000104	0.000374	CbGpPWpGaD
Acitretin—RBP1—Disease—CTNNB1—pancreatic cancer	0.000104	0.000373	CbGpPWpGaD
Acitretin—Pruritus—Doxorubicin—pancreatic cancer	0.000104	0.000179	CcSEcCtD
Acitretin—RXRA—Developmental Biology—MET—pancreatic cancer	0.000104	0.000372	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—HSPA1B—pancreatic cancer	0.000103	0.00037	CbGpPWpGaD
Acitretin—RARB—Gene Expression—NOTCH1—pancreatic cancer	0.000102	0.000367	CbGpPWpGaD
Acitretin—RBP1—Disease—PTEN—pancreatic cancer	0.000102	0.000364	CbGpPWpGaD
Acitretin—Vomiting—Epirubicin—pancreatic cancer	0.000101	0.000174	CcSEcCtD
Acitretin—CYP26A1—Metabolism—PPARG—pancreatic cancer	0.000101	0.000362	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TP53—pancreatic cancer	0.000101	0.000361	CbGpPWpGaD
Acitretin—Diarrhoea—Doxorubicin—pancreatic cancer	0.000101	0.000173	CcSEcCtD
Acitretin—Rash—Epirubicin—pancreatic cancer	0.0001	0.000172	CcSEcCtD
Acitretin—RXRA—Generic Transcription Pathway—PPARG—pancreatic cancer	0.0001	0.000359	CbGpPWpGaD
Acitretin—Dermatitis—Epirubicin—pancreatic cancer	0.0001	0.000172	CcSEcCtD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—pancreatic cancer	0.0001	0.000358	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—NOTCH1—pancreatic cancer	0.0001	0.000358	CbGpPWpGaD
Acitretin—Headache—Epirubicin—pancreatic cancer	9.96e-05	0.000171	CcSEcCtD
Acitretin—RXRG—Gene Expression—PPARG—pancreatic cancer	9.85e-05	0.000353	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—NOTCH1—pancreatic cancer	9.81e-05	0.000351	CbGpPWpGaD
Acitretin—RARA—Gene Expression—NOTCH1—pancreatic cancer	9.81e-05	0.000351	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	9.77e-05	0.00035	CbGpPWpGaD
Acitretin—Dizziness—Doxorubicin—pancreatic cancer	9.73e-05	0.000167	CcSEcCtD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	9.68e-05	0.000347	CbGpPWpGaD
Acitretin—RARB—Gene Expression—PPARG—pancreatic cancer	9.66e-05	0.000346	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GLP1R—pancreatic cancer	9.45e-05	0.000339	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	9.45e-05	0.000338	CbGpPWpGaD
Acitretin—Nausea—Epirubicin—pancreatic cancer	9.45e-05	0.000162	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—PIK3CD—pancreatic cancer	9.44e-05	0.000338	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—PPARG—pancreatic cancer	9.44e-05	0.000338	CbGpPWpGaD
Acitretin—RBP1—Disease—SRC—pancreatic cancer	9.42e-05	0.000337	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—EZH2—pancreatic cancer	9.41e-05	0.000337	CbGpPWpGaD
Acitretin—Vomiting—Doxorubicin—pancreatic cancer	9.35e-05	0.000161	CcSEcCtD
Acitretin—RXRA—Metabolism—DPYD—pancreatic cancer	9.3e-05	0.000333	CbGpPWpGaD
Acitretin—Rash—Doxorubicin—pancreatic cancer	9.28e-05	0.00016	CcSEcCtD
Acitretin—Dermatitis—Doxorubicin—pancreatic cancer	9.27e-05	0.000159	CcSEcCtD
Acitretin—RARA—Gene Expression—PPARG—pancreatic cancer	9.26e-05	0.000332	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—PPARG—pancreatic cancer	9.26e-05	0.000332	CbGpPWpGaD
Acitretin—Headache—Doxorubicin—pancreatic cancer	9.22e-05	0.000159	CcSEcCtD
Acitretin—RXRA—Gene Expression—NOTCH3—pancreatic cancer	9.21e-05	0.00033	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CD—pancreatic cancer	9.21e-05	0.00033	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—TNF—pancreatic cancer	9.09e-05	0.000325	CbGpPWpGaD
Acitretin—RBP1—Disease—STAT3—pancreatic cancer	9.08e-05	0.000325	CbGpPWpGaD
Acitretin—RBP1—Disease—NRAS—pancreatic cancer	9.06e-05	0.000325	CbGpPWpGaD
Acitretin—RXRA—Metabolism—SLC2A2—pancreatic cancer	8.82e-05	0.000316	CbGpPWpGaD
Acitretin—Nausea—Doxorubicin—pancreatic cancer	8.74e-05	0.00015	CcSEcCtD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.73e-05	0.000313	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—HSPA1A—pancreatic cancer	8.72e-05	0.000312	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MMP2—pancreatic cancer	8.66e-05	0.00031	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	8.59e-05	0.000308	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	8.49e-05	0.000304	CbGpPWpGaD
Acitretin—RBP1—Disease—MYC—pancreatic cancer	8.44e-05	0.000302	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	8.43e-05	0.000302	CbGpPWpGaD
Acitretin—RBP1—Disease—TGFB1—pancreatic cancer	8.42e-05	0.000302	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	8.39e-05	0.0003	CbGpPWpGaD
Acitretin—RBP1—Disease—EGFR—pancreatic cancer	8.26e-05	0.000296	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CB—pancreatic cancer	8.23e-05	0.000295	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CB—pancreatic cancer	8.02e-05	0.000287	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	7.98e-05	0.000286	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTGS2—pancreatic cancer	7.95e-05	0.000285	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CXCL8—pancreatic cancer	7.91e-05	0.000283	CbGpPWpGaD
Acitretin—RBP1—Disease—KRAS—pancreatic cancer	7.8e-05	0.000279	CbGpPWpGaD
Acitretin—ALB—Hemostasis—CD44—pancreatic cancer	7.69e-05	0.000275	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.68e-05	0.000275	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CASP3—pancreatic cancer	7.57e-05	0.000271	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	7.46e-05	0.000267	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IFNA1—pancreatic cancer	7.44e-05	0.000267	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CCND1—pancreatic cancer	7.37e-05	0.000264	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CTNNB1—pancreatic cancer	7.3e-05	0.000261	CbGpPWpGaD
Acitretin—RBP1—Disease—PIK3CA—pancreatic cancer	7.16e-05	0.000257	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MMP9—pancreatic cancer	7.15e-05	0.000256	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PTEN—pancreatic cancer	7.11e-05	0.000255	CbGpPWpGaD
Acitretin—ALB—Metabolism—PRSS1—pancreatic cancer	7.06e-05	0.000253	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—SMAD4—pancreatic cancer	6.94e-05	0.000248	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTEN—pancreatic cancer	6.93e-05	0.000248	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IFNA2—pancreatic cancer	6.93e-05	0.000248	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CD44—pancreatic cancer	6.83e-05	0.000245	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.69e-05	0.00024	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—CTNNB1—pancreatic cancer	6.64e-05	0.000238	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.63e-05	0.000237	CbGpPWpGaD
Acitretin—RBP1—Disease—HRAS—pancreatic cancer	6.63e-05	0.000237	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SRC—pancreatic cancer	6.6e-05	0.000236	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GCG—pancreatic cancer	6.55e-05	0.000235	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MMP9—pancreatic cancer	6.51e-05	0.000233	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	6.5e-05	0.000233	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—VEGFA—pancreatic cancer	6.42e-05	0.00023	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—STAT3—pancreatic cancer	6.36e-05	0.000228	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NRAS—pancreatic cancer	6.35e-05	0.000227	CbGpPWpGaD
Acitretin—RXRA—Metabolism—STK11—pancreatic cancer	6.16e-05	0.000221	CbGpPWpGaD
Acitretin—RARG—Gene Expression—MYC—pancreatic cancer	6.14e-05	0.00022	CbGpPWpGaD
Acitretin—ALB—Metabolism—ARG2—pancreatic cancer	6.12e-05	0.000219	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—SRC—pancreatic cancer	6e-05	0.000215	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MYC—pancreatic cancer	5.91e-05	0.000212	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TGFB1—pancreatic cancer	5.9e-05	0.000211	CbGpPWpGaD
Acitretin—RBP1—Disease—AKT1—pancreatic cancer	5.85e-05	0.00021	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—VEGFA—pancreatic cancer	5.85e-05	0.000209	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—STAT3—pancreatic cancer	5.79e-05	0.000207	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.78e-05	0.000207	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—EGFR—pancreatic cancer	5.78e-05	0.000207	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—NRAS—pancreatic cancer	5.78e-05	0.000207	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—MYC—pancreatic cancer	5.72e-05	0.000205	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MYC—pancreatic cancer	5.62e-05	0.000201	CbGpPWpGaD
Acitretin—RARB—Gene Expression—MYC—pancreatic cancer	5.51e-05	0.000197	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KRAS—pancreatic cancer	5.46e-05	0.000196	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—TGFB1—pancreatic cancer	5.37e-05	0.000192	CbGpPWpGaD
Acitretin—ALB—Metabolism—TYMP—pancreatic cancer	5.35e-05	0.000192	CbGpPWpGaD
Acitretin—RXRA—Metabolism—TYMS—pancreatic cancer	5.3e-05	0.00019	CbGpPWpGaD
Acitretin—RARA—Gene Expression—MYC—pancreatic cancer	5.28e-05	0.000189	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MYC—pancreatic cancer	5.28e-05	0.000189	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—EGFR—pancreatic cancer	5.26e-05	0.000188	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	5.21e-05	0.000187	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—NOTCH1—pancreatic cancer	5.11e-05	0.000183	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	5.08e-05	0.000182	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CA—pancreatic cancer	5.02e-05	0.00018	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—TNF—pancreatic cancer	5.01e-05	0.000179	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—KRAS—pancreatic cancer	4.97e-05	0.000178	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PLAU—pancreatic cancer	4.92e-05	0.000176	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CA—pancreatic cancer	4.89e-05	0.000175	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TP53—pancreatic cancer	4.85e-05	0.000174	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—PPARG—pancreatic cancer	4.83e-05	0.000173	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	4.66e-05	0.000167	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—HRAS—pancreatic cancer	4.64e-05	0.000166	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.41e-05	0.000158	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CG—pancreatic cancer	4.37e-05	0.000157	CbGpPWpGaD
Acitretin—ALB—Hemostasis—EGF—pancreatic cancer	4.32e-05	0.000155	CbGpPWpGaD
Acitretin—ALB—Metabolism—GLP1R—pancreatic cancer	4.31e-05	0.000154	CbGpPWpGaD
Acitretin—RXRA—Metabolism—APOE—pancreatic cancer	4.31e-05	0.000154	CbGpPWpGaD
Acitretin—RARG—Gene Expression—AKT1—pancreatic cancer	4.26e-05	0.000153	CbGpPWpGaD
Acitretin—ALB—Metabolism—DPYD—pancreatic cancer	4.24e-05	0.000152	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—HRAS—pancreatic cancer	4.23e-05	0.000151	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—AKT1—pancreatic cancer	4.1e-05	0.000147	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.08e-05	0.000146	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC2A2—pancreatic cancer	4.02e-05	0.000144	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—AKT1—pancreatic cancer	4e-05	0.000143	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.98e-05	0.000143	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	3.96e-05	0.000142	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—AKT1—pancreatic cancer	3.89e-05	0.000139	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CG—pancreatic cancer	3.89e-05	0.000139	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CD—pancreatic cancer	3.85e-05	0.000138	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.84e-05	0.000138	CbGpPWpGaD
Acitretin—RARB—Gene Expression—AKT1—pancreatic cancer	3.82e-05	0.000137	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PPARG—pancreatic cancer	3.75e-05	0.000134	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—AKT1—pancreatic cancer	3.73e-05	0.000134	CbGpPWpGaD
Acitretin—RARA—Gene Expression—AKT1—pancreatic cancer	3.66e-05	0.000131	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—AKT1—pancreatic cancer	3.66e-05	0.000131	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.5e-05	0.000125	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CD—pancreatic cancer	3.42e-05	0.000122	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CB—pancreatic cancer	3.35e-05	0.00012	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	3.24e-05	0.000116	CbGpPWpGaD
Acitretin—ALB—Metabolism—CD44—pancreatic cancer	3.12e-05	0.000112	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.05e-05	0.000109	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.02e-05	0.000108	CbGpPWpGaD
Acitretin—ALB—Metabolism—GCG—pancreatic cancer	2.99e-05	0.000107	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CB—pancreatic cancer	2.98e-05	0.000107	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTGS2—pancreatic cancer	2.95e-05	0.000106	CbGpPWpGaD
Acitretin—ALB—Metabolism—STK11—pancreatic cancer	2.81e-05	0.000101	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MYC—pancreatic cancer	2.75e-05	9.86e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—SRC—pancreatic cancer	2.69e-05	9.62e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.64e-05	9.45e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—VEGFA—pancreatic cancer	2.62e-05	9.37e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—NRAS—pancreatic cancer	2.58e-05	9.26e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTEN—pancreatic cancer	2.57e-05	9.22e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—TYMS—pancreatic cancer	2.42e-05	8.66e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TGFB1—pancreatic cancer	2.4e-05	8.6e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—KRAS—pancreatic cancer	2.22e-05	7.97e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CA—pancreatic cancer	2.04e-05	7.32e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TP53—pancreatic cancer	1.98e-05	7.08e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—APOE—pancreatic cancer	1.97e-05	7.04e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—AKT1—pancreatic cancer	1.91e-05	6.84e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—HRAS—pancreatic cancer	1.89e-05	6.77e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.86e-05	6.66e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CA—pancreatic cancer	1.82e-05	6.51e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CG—pancreatic cancer	1.77e-05	6.35e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PPARG—pancreatic cancer	1.71e-05	6.13e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—AKT1—pancreatic cancer	1.67e-05	5.98e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CD—pancreatic cancer	1.56e-05	5.58e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—AKT1—pancreatic cancer	1.48e-05	5.31e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CB—pancreatic cancer	1.36e-05	4.87e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTGS2—pancreatic cancer	1.35e-05	4.82e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTEN—pancreatic cancer	1.17e-05	4.21e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CA—pancreatic cancer	8.28e-06	2.97e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—AKT1—pancreatic cancer	6.77e-06	2.42e-05	CbGpPWpGaD
